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Background: RNA-Seq has enabled high-throughput gene expression profiling to provide insight into the functional link
between genotype and phenotype. Low quantities of starting RNA can be a severe hindrance for studies that aim to
utilize RNA-Seq. To mitigate this bottleneck, whole transcriptome amplification (WTA) technologies have been developed
to generate sufficient sequencing targets from minute amounts of RNA. Successful WTA requires accurate replication of
transcript abundance without the loss or distortion of specific mRNAs. Here, we test the efficacy of NuGEN’s
Ovation RNA-Seq V2 system, which uses linear isothermal amplification with a unique chimeric primer for amplification,
using white adipose tissue from standard laboratory rats (Rattus norvegicus). Our goal was to investigate potential
biological artifacts introduced through WTA approaches by establishing comparisons between matched raw and
amplified RNA libraries derived from biological replicates.
Results: We found that 93% of expressed genes were identical between all unamplified versus matched amplified
comparisons, also finding that gene density is similar across all comparisons. Our sequencing experiment and
downstream bioinformatic analyses using the Tuxedo analysis pipeline resulted in the assembly of 25,543 high-quality
transcripts. Libraries constructed from raw RNA and WTA samples averaged 15,298 and 15,253 expressed genes,
respectively. Although significant differentially expressed genes (P < 0.05) were identified in all matched samples,
each of these represents less than 0.15% of all shared genes for each comparison.
Conclusions: Transcriptome amplification is efficient at maintaining relative transcript frequencies with no
significant bias when using this NuGEN linear isothermal amplification kit under ideal laboratory conditions as
presented in this study. This methodology has broad applications, from clinical and diagnostic, to field-based
studies when sample acquisition, or sample preservation, methods prove challenging.
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RNA-Seq is quickly becoming the preferred method for
comprehensively characterizing global transcriptome ac-
tivity. This approach has emerged as a powerful tool for
determining the link between genotype and phenotype
given that the transcriptomes of specific tissue types and
individual cells reflect functionality [1-4]. Monitoring
changes in gene expression across thousands of genes
simultaneously provides an untargeted view of the mo-
lecular workings that contribute to adaptive responses to
extrinsic and intrinsic stimuli [5,6]. When conducting
RNA-Seq studies, one potential obstacle encountered by
researchers can result from suboptimal starting quantities* Correspondence: sheena.faherty@duke.edu
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creativecommons.org/publicdomain/zero/1.0/of RNA that the use of NGS platforms often requires. This
can be especially problematic for certain tissue types
wherein starting RNA is in low quantities, such a white
adipose tissue, or when using minimally invasive tech-
niques to acquire samples [7-10]. Many of these ap-
proaches yield considerably less than a microgram of
total RNA [11-16] though current library preparation
protocols are typically optimized for a minimum of one
microgram of total RNA.
Technologies are emerging to circumvent these chal-
lenges. With whole transcriptome amplification (WTA),
RNA can be synthetically enriched for gene profiling ex-
periments with both research and diagnostic applications
[12,17-19]. WTA amplifies the transcriptome, even in
the face of low starting material and/or when samples
are heavily degraded due to insufficient preservation [5].rticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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high fidelity RNA amplification, therefore, have tremendous
appeal for numerous applications spanning the disciplines
of field ecology to biomedical diagnostics [12,17,18].
An obvious concern when using WTA for sensitive
RNA-Seq is that the replication of transcript abundance
occurs without the loss or distortion of transcript expres-
sion. Using technologies such as quantitative polymerase
chain reaction (qPCR) or microarrays to measure expres-
sion levels investigators have compared expression profiles
from i.) amplification of varying amounts of starting total
RNA [5,20,21]; ii.) amplified and unamplified RNA from
the same source [5,14,22,23]; iii.) different commercially
available kits or lab-based techniques [20,21,24-26]. These
studies are valuable proxies for assessing amplification
bias, but these technologies can be limited in their detec-
tion capabilities [12,14]. NGS approaches have greater
resolution over qPCR and microarrays, and can detect
changes in gene expression on a finer scale with digital
precision in which one digital unit represents a single
mapped sequence read [3,27]. It is therefore critical to
assess the accuracy of transcript amplification with the
highest resolution technology, particularly when inves-
tigators are choosing NGS over other techniques in
current experimental methodologies.
Commercially available kits are becoming increas-
ingly prevalent for seamless incorporation of amplified
RNA into the NGS pipeline. These are offered by com-
panies such as Clontech, Sigma, Miltenyi Biotec, and
NuGEN, and use a variety of techniques to amplify
RNA. When considering WTA for RNA-Seq studies, it
is important to carefully consider the differences in
chemistry and approaches that each commercial kit uti-
lizes. Variations in priming strategies, cDNA synthesis,
and amplification of newly converted cDNA can have
impacts on length of cDNA products, 3′ bias, amplifi-
cation efficiency, and fidelity of maintaining relative
transcript abundance [1]. All of these factors can po-
tentially introduce unwanted bias in expression studies
using RNA-Seq. A researcher limited to using samples
collected from the field or from heavily degraded clin-
ical specimens, for example, might consider choosing a
kit that uses both oligo (dT) and random hexamers
primers for reverse transcription. This might alleviate
the potential mis-amplification due to the loss of the
poly-A tail from RNA degradation. NuGEN’s Ovation
RNA-Seq V2 kit is based on the linear isothermal amp-
lification of double-stranded cDNA that encompasses a
unique RNA/DNA heteroduplex at one end using the
RNA-dependent DNA polymerase activity [5]. Amplifi-
cation is initiated at the 3′ end as well as randomly
throughout the whole transcriptome in the sample,
using both oligoDT and random hexamer primers. This
approach will putatively yield a uniform and accuraterepresentation of the transcriptome, an assumption that
we directly test in this study.
As commercially available WTA kits continue to im-
prove, investigators should continually reassess their ef-
ficiency and compatibility with new sequencing
platforms, to determine the best practices as methods
evolve. In previous work, Tariq et al. (2011) performed
an exploration of the efficacy of the NuGEN Ovation
RNA-Seq system by using two different library preparation
protocols to reduce ribosomal RNA contamination (i.e.
poly-A enrichment and rRNA depletion), and ran their
sequencing experiment on two separate sequencing
platforms, the SOLiD platform and the Illumina Genome
Analyzer IIX, to assess sequencing fidelity and platform-
specific biases. Notably, this study attempted to identify
the best combination of approaches (i.e. which combin-
ation of library preparation protocols and sequencing plat-
forms) will result in the largest amount of high quality
data generated from a WTA sample for RNA-Seq
characterization. As comprehensive as this investigation
was, the authors neglected to determine how WTA tech-
nologies, such as the Ovation kit, influence gene expres-
sion profiles. Their investigation was instead limited to
evaluating differential gene expression between the two se-
quencing platforms. In addition, since the publication of
that study, NuGEN has released an enhanced version of
their Ovation kit and Illumina sequencing technology has
become more advanced with the advent of their HiSeq
platform. In particular, the HiSeq boasts lower error rates,
better precision, and longer reads than the GAIIX [7].
Moreover, Shanker et al. (2015) recently conducted a
broad-scale investigation of the reproducibility of four
commercially-available kits, including NuGEN’s Ovation
RNA-Seq V2 system, at multiple laboratories using three
varying amounts of starting concentrations on the Illu-
mina HiSeq platform. They find that NuGEN performs re-
markably well across multiple laboratories and across
technical replicates as low as 500 pg [28]. With RNA-Seq
data, however, the largest variability is known to come
from biological stochasticity rather than from technical
inaccuracies [29,30].
It remains unknown whether WTA preferentially amp-
lifies specific gene products to the exclusion of others.
Therefore, our study integrated the design of matched
amplified and unamplified RNA from six biological rep-
licates to empirically test this question using NGS tran-
scriptomic sequencing on the Illumina HiSeq 2000
platform, which has become the gold standard for next-
generation sequencing experiments [11,13,15,16]. In the
present study, we aim to investigate the degree to which
NuGEN’s Ovation RNA-Seq V2 system influences gene
expression profiles in white adipose tissue excised from
standard laboratory rats (Rattus norvegicus), building
upon and enhancing knowledge regarding current WTA
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lysis pipeline [2-4,31] to assemble our RNA-Seq reads
using the R. norvegicus genome, in addition to providing
annotation and an exploration of differentially expressed
genes. Our study was designed to sequence samples at
the greatest depth possible, given the resources at hand,
in order to identify any subtle differences between raw
RNA and amplified RNA in biological replicates. Ultim-
ately, our goal is to provide foundational insight for fu-
ture studies to build upon regarding the utility of WTA
for clinical and field-based studies that are investigating
the functional link between genotype and phenotype via
gene expression and RNA-Seq.
Results
We sequenced over 829 million paired-end reads, 2 ×100
base pairs in length (Lane 1 = 368,942,612, Lane 2 =
460,712,194 reads). Quality filtering resulted in the reten-
tion of approximately 90% and 86% of reads from Lanes 1
and 2, respectively (Table 1). Approximately 62% of all
reads successfully mapped to the R. norvegicus genome
(Table 1; Additional file 1: Table S1). Transcript assembly
using Cufflinks resulted in 25,543 assembled transcripts.
We identified strong correlations in gene expression
within each of the six pairwise comparisons of matched
raw RNA and amplified RNA, and FPKM (fragments per
kilobase of exon per million fragments mapped) values
averaged slightly higher in libraries constructed from
raw RNA samples (Figure 1). Transcripts with FPKM
values greater than 0.05 were identified as being
expressed (i.e. above the expected false discovery rate
following Trapnell et al. 2010), and this threshold was
used to determine the number of expressed genes for
each sample. Libraries constructed from raw RNA and
WTA samples averaged 15,298 and 15,253 expressed
genes, respectively (Table 1; Additional file 1: Table S1).
Approximately 93% of expressed genes were identical
between each of the six matched raw RNA and WTA
comparisons (Table 1, Figure 2) and gene density was
similar across all samples (Figure 3). Using Cuffdiff, sig-
nificant differentially expressed genes (P < 0.05) wereTable 1 Summary of sequencing results, quality filtering,
and transcript assembly from pooled raw RNA samples
vs. pooled WTA samples
Raw RNA WTA
Total sequenced reads 368,942,612 460,712,194
Filtered reads 334,297,804 395,807,422
Aligned reads 208,496,473 241,691,534
Uniquely aligned reads 173,011,711 221,886,287
Multiple aligned reads 35,484,762 19,805,247
Unmapped reads 121,884,321 152,473,973
Avg. expressed genes 15,298 15,253identified in four of the six comparisons (Table 2), with
each of these representing less than 0.15% of all shared
genes for each comparison. This percentage is represen-
tative of 54 genes, in total, that show differences in ex-
pression levels when comparing unamplified vs.
amplified. Of the 54 differentially expressed genes, 19
are identified as putative in the Ensembl database as
pseudo-genes, while 35 represent functional protein-
coding genes, and of those that are protein-coding, 33%
percent have homology to human, while the others are
putatively rat-specific.
As a complimentary bioinformatic approach to investi-
gate potential differential gene expression, we used HT-
Seq [32] to quantify reads by gene, and DESeq [33] to
compare these quantities across biological replicates. We
find less than 0.14% of genes expressed display differen-
tial expression when comparing raw vs. amplified RNA
from biological replicates (Table 2). This percentage is
representative of 31 genes that show differential expres-
sion between unamplified and amplified matched pairs.
We next assessed potential biases in transcript repre-
sentation (i.e. coverage at 3′ and 5′ end) by determining
the average coverage at each percentile of length from 3′
to 5′ end of the known transcripts (Figure 4). The cover-
age depth analysis at the extreme 3′ and 5′ ends of the
transcripts confirms 3′ bias for all of our samples inde-
pendent of WTA treatment and is likely an artifact of
library creation, which were prepared using a poly-A-
based enrichment method.
Discussion
RNA-Seq has enabled the sequencing of transcriptomes
to allow both identification and quantification of tran-
script levels. The digital precision and sensitivity of
RNA-Seq is well-suited to the analysis of low-input or
degraded samples, especially with respect to older
methods such as qPCR or microarrays, yet many avail-
able protocols require total RNA around 1.0 microgram,
presenting a potential obstacle for clinical or field-based
studies. Here, we have tested the efficacy of NuGEN’s
Ovation RNA-Seq V2 system for whole transcriptome
amplification by comparing matched amplified and un-
amplified samples to identify if there exists any subtle
changes in gene expression after WTA among biological
replicates. We were specifically interested in investigat-
ing the degree to which accurate representations of gene
diversity and transcript abundance levels were achieved
when sequenced on an Illumina HiSeq.
Gene expression patterns in unamplified versus amplified
libraries
We identified consistent patterns of gene presence and ab-
sence across each of the six comparisons, with an average
overlap of approximately 93%. We found no evidence that
Figure 1 Gene expression scatterplots. FPKM values for all transcripts were plotted, with each dot representing a single transcript. Solid blue lines
show the best fit of the data and the dashed line identifies equal expression levels across both conditions.
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expressed in matched unamplified vs. amplified RNA in
this study. Using Cuffdiff, the only gene found to be differ-
entially expressed in as many as four of the six sample
pairs was classified as a pseudo-gene and one protein-
coding gene, heterogeneous nuclear ribonucleoprotein A0(Hnrnpa0), a DNA binding protein that is thought to in-
fluence pre-mRNA processing, mRNA metabolism and
transport, was found to be differentially expressed in three
out of the six sample pairs. The remaining differentially
expressed genes were only found in two or fewer compari-
sons, and no pairwise comparison shared more than five
Figure 2 Venn diagram showing overlap among expressed genes.
Expressed genes are identified within raw RNA and WTA libraries
from all six R. norvegicus samples.
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no consistent biological distortion, as 48% (15 out of 31)
of differentially expressed genes were found in five or
fewer of our pairwise comparisons. This result is remark-
ably consistent with the differential expression results pro-
duced using Cuffdiff. Moreover, we observe no overlap
with the genes that Cuffdiff identified as differentially
expressed, indicative of the small proportion of differen-
tially expressed genes being a product of background
noise from stochastic events observed with typical RNA-
Seq experiments. This result thus lends strong support to
our hypothesis that there is no consistent biological distor-
tion when using WTA.Testing the efficacy of NuGEN’s Ovation RNA-Seq V2 kit
Only a few studies have thus far investigated potential
biases in gene expression introduced by WTA ap-
proaches using NuGEN’s WTA technology [5,21,28,34].
These studies have been foundational in determining
that the WTA chemistry tested herein performs well
across technical replicates of varying amounts of starting
material down to the limits of 50–100 pg. However, to
our knowledge, no previous work has included biological
replicates in their analyses. Thus, the strength of our in-
vestigation is that it incorporates the experimental de-
sign of matched amplified and unamplified RNA from
six biological replicates to test for preferential amplifica-
tion of WTA approaches. In the present study, we do
not find that WTA selectively amplifies specific gene
products and the small variability observed among repli-
cates is most likely attributed to background noise. Bio-
logical replicates are essential for identifying potential
distortion from gene expression stochasticity inherent in
any biological system.We chose NuGEN’s Ovation kit based upon the sin-
gle primer isothermal amplification (SPIA) technology
for achieving WTA. This technology incorporates a
combination of 3’-Ribo-SPIA (i.e. polydT) primers,
which prime synthesis of cDNA at the 3’ polyA tail,
and whole transcript (WT)-Ribo-SPIA (i.e. random
hexamer) primers to prime cDNA synthesis across the
full length of the transcripts, providing amplification
independent of sample degradation at the 3’ end
[5,8-10,35]. Ideally, this feature makes the Ovation
RNA-Seq System V2 kit useful for NGS platforms, such
as the Illumina HiSeq which function by distributing
reads across the entire length of the transcript. Previ-
ous studies have also found that commercial kits show
high reproducibility in WTA procedures completed by
researchers in different laboratories (correlation coeffi-
cient of ~0.95), thus providing encouraging support for
the use of WTA prior to sequencing when working
with challenging samples [12,14,21].
Utility of whole transcriptome amplification for non-model
species or field-based studies
Studies that investigate the relationship between geno-
type and phenotype have largely focused on model or-
ganisms for which a genome is publicly available, and
have been performed using captive populations, or with
cell culture methods under controlled laboratory settings
for which sample material is relatively easy to obtain
[12,17,18,36-46]. Although these studies provide a
wealth of vital information on the drivers of physiology,
behavior, and disease dynamics, comparable studies on
non-model organisms or studies that use crucial patho-
logical specimens (e.g. laser capture microdissection,
FFPE, or biopsied tissue) or samples collected in the
field remain scarce. This is due to the challenging nature
of working with these sample types, often adding an-
other layer of complexity (e.g. potential degradation) to
the already present challenge of low RNA input
[5,12,20,21,47-50]. Potential degradation is due to the
fact that RNA is highly sensitive to endogenous and ex-
ogenous RNases, which rapidly degrade RNA molecules
at ambient conditions [5,14,22,23,51,52]. Degradation
can result in immediate changes in expression profiles
or a prospective loss of rare transcripts immediately after
sample collection [20,21,24-26,53,54]. Although, this issue
may be unavoidable for certain experiments, the priming
strategy of the NuGEN kit may alleviate potential down-
stream issues when using partially degraded samples.
Conclusions
Our study builds upon and enhances existing knowledge
regarding the NuGEN Ovation RNA-Seq V2 system’s
performance in studies that use WTA for RNA-Seq ex-
periments. Previous studies have demonstrated that this
Figure 3 Distribution of gene expression levels across each sample/condition. Comparative distribution analysis of reads correlated to gene
density in rat white adipose tissue.
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Table 2 Number of significant differentially expressed genes (P < 0.05) per individual identified using Cuffdiff and DESeq
Cuffdiff DESeq
Differentially expressed
genes (Raw RNA vs. WTA)
Percent of total shared
genes between conditions
Differentially expressed
genes (Raw RNA vs. WTA)
Percent of total shared
genes between conditions
Rat 1 0 - 20 0.11%
Rat 2 16 0.11% 15 0.08%
Rat 3 19 0.14% 23 0.13%
Rat 4 18 0.13% 22 0.12%
Rat 5 0 - 22 0.12%
Rat 6 17 0.12% 25 0.14%
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varying starting amounts of input RNA and across mul-
tiple laboratories. The novelty of our study is that it empir-
ically tests biological variation, by incorporating the design
of matched amplified and unamplified RNA from six bio-
logical replicates. The Ovation RNA-Seq V2 kit is able to
amplify small quantities of RNA from tissue samples while
maintaining transcript levels nearly identical to those from
matched unamplified input RNA, demonstrating an over-
lap of 93% when comparing each matched pair individu-
ally. Despite this high fidelity of transcript representation,
future studies should anticipate the slight discrepancy re-
vealed here and take measures to account for the potential
for small differences in downstream analyses. Additionally,
future work could benefit from testing this methodology
using more realistic scenarios, such as repeating the ex-
periment with smaller input concentrations, or using
partially degraded samples that may be more represen-
tative of RNA that may be extracted from clinical or
from field-based studies. Nonetheless, this study provides
the essential first step into investigations into the putative




Animal handling was carried out in strict accordance
with the approval of Duke University’s Institutional Ani-
mal Care and Use Committee (IACUC protocol #A096-
13-04). Gonadal white adipose tissue was excised from
standard laboratory rats (Rattus norvegicus, n = 6) and
snap frozen in liquid nitrogen. Samples were transferred
to −80°C and stored there until sample processing.
RNA extraction
Approximately 100 mg of white adipose tissue was used
for total RNA extraction. RNA was purified using an op-
timized TRIzol protocol in conjunction with the Micro-
array Tissue Kit (Qiagen; Valencia, CA, USA). Briefly,
frozen tissues were homogenized in 1 ml TRI Reagent
(Ambion; Grand Island, NY, USA) using a hand-held
rotor-stator homogenizer to provide efficient disruptionand homogenization of samples. BCP (1-bromo-3-chlor-
opropane) extraction was performed using 100 ul of
BCP, followed by centrifugation at 12,000 × g for 15 min
at 4°C. Aqueous layer containing total RNA was trans-
ferred to a fresh 1.5 ml centrifuge tube and one volume
of 70% EtOH was added to sample. The entire sample
volume was loaded onto Qiagen filter columns and kit
protocol was followed according to manufacturer’s in-
structions, including an on-column DNase step to re-
move residual contaminating DNA before amplification
and downstream sequencing.
RNA integrity and concentration was assessed using
the 2100 Bioanalyzer (Agilent Technologies; Santa Clara,
CA, USA) at the Duke Institute for Genome Science and
Policy’s Microarray Facility. RNA integrity is provided by
a RNA Integrity Number (RIN), which is calculated
based on the comparison of the areas of 18S rRNA and
28 s rRNA [12,14,55]. Values range from 1 being the
most degraded to 10 being the most intact. RIN values
for our total RNA extractions ranged from 9.2 – 9.4, a
measure of high quality (Additional file 2: Figure S1).
Total RNA concentrations ranged from 200–300 ng/ul.
Whole transcriptome amplification
Total RNA extractions were divided into two tubes for
each rat, for a total of 12 tubes. Six tubes were nor-
malized to 100 ng/μl in a 5 μl volume, for a total of
500 ng of RNA, and subjected to whole transcriptome
amplification using NuGEN’s Ovation RNA-Seq V2 kit
(San Carlos, CA, USA) according to manufacturer’s in-
structions. This kit provides a rapid method for preparing
amplified cDNA from total RNA for downstream RNA-
Seq applications. It employs a single primer isothermal
amplification (SPIA) method to amplify total RNA into
double stranded cDNA and depletes rRNA without prese-
lecting mRNA. Amplified cDNA samples were then puri-
fied using the MinElute Reaction Cleanup Kit (Qiagen;
Valencia, CA, USA) according to manufacturer’s protocol.
After the amplification procedure, cDNA concentrations
ranged from 421–575 ng/ul (Additional file 1: Table S2).
Paired amplified cDNA (n = 6) and unamplified raw RNA
samples (n = 6) were then sent to Duke GCB Genome
Figure 4 RNA-Seq read coverage of rat gene models. (A) Coverage across all transcripts based on mapping of transcriptome reads to the Rattus
norvegicus genome. All samples showed similar 3′ bias. (B) Heat map showing read coverage across all rat genes. Samples are ranked according
to Pearson’s skewness coefficients.
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sequencing.Library preparation and sequencing
Total RNA samples were converted to cDNA libraries
using Illumina’s TruSeq RNA Sample Preparation Kit
(San Diego, CA, USA). In summary, 1 μg of total RNA
was enriched for mRNA using oligo-dT coated magnetic
beads, fragmented, and reverse transcribed into cDNA.
The cDNA was fragmented into smaller pieces, blunt-
ended, and ligated to indexed (barcoded) adaptors and
amplified using PCR. Previously amplified cDNA libraries
were prepared for sequencing using Illumina’s TruSeq
DNA Sample Preparation Kit according to manufacturer’s
protocol. Final library size distribution was determined
using Agilent Bioanalyzer 2100. Insert size was between
120–130 base pairs (bp) and average library size was
230 bp. Twelve libraries were multiplexed, pooled and se-
quenced on two lanes of the Illumina HiSeq2000 platform
(San Diego, CA, USA) using 100 bp paired-end reads. Spe-
cifically, six multiplexed non-amplified samples were se-
quenced on Lane 1, while six multiplexed amplified
samples were sequenced on Lane 2. The data set support-
ing the results of this article are available in the NCBI Short
Read Archive repository [accession number SRP049463;
http://www.ncbi.nlm.nih.gov/sra/?term=SRP049463].Read mapping and transcriptome assembly
RNA-Seq reads were filtered using the Trimmomatic
program [56] and aligned to the R. norvegicus genome
(Rnor_5.0; downloaded from Ensembl.org on 3/2014)
using TopHat2 (v 2.0.5) [3,27,57]. The resulting alignment
data from TopHat2 were then fed into Cufflinks (v 2.0.2)
to assemble aligned RNA-Seq reads into transcripts for
each rat individually. Annotated transcripts were obtained
from Ensembl database (Rnor_5.0.75.gtf; downloaded
from Ensembl.org on 3/2014). Transcript abundances esti-
mates were measured in FPKM. Cuffdiff was used to de-
termine differential gene expression profiles between
amplified and unamplified matched samples for each bio-
logical replicate included in our study [58]. HTSeq was
used under default parameters to produce gene counts for
each of our twelve samples [32]. To estimate differential
expression, we fed the matrix of read counts generated by
HTSeq into DESeq [33]. Since we were working with bio-
logical, and not technical replicates, we reduced the read
counts to two conditions for each sample (amplified and
raw) and estimated dispersion by ignoring condition and
treating all samples as if they were replicates of the same
condition. We used the option sharingMode = “fit-only” to
retain outliers, accounting for biological replications in
our experimental design. The geneBody_coverage.py script
within the RseqC package [59] was used to examine readcoverage across gene models and test for 5′ and 3′ bias in
transcript coverage.
Additional files
Additional file 1: Table S1. Summary of sequencing results, quality
filtering, and transcript assembly from biological replicates included in
our analysis. Table S2. Summary of pre- and post-amplification RNA
concentrations.
Additional file 2: Figure S1. Agilent Bioanalyzer traces demonstrate
total RNA extractions are high-quality.
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